Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joon W Shim

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Biomedicines|March 25, 2022
Drug-Targeted Genomes: Mutability of Ion Channels and GPCRsRegan Raines, Ian McKnight, Hunter White, et al.
Frontiers in Neuroscience|May 21, 2025
NFκB1: a common biomarker linking Alzheimer's and Parkinson's disease pathologyAdam Cunningham, Emma Barrett, Sebastian Risch, et al.
Scientific Reports|June 1, 2016
Excess HB-EGF, which promotes VEGF signaling, leads to hydrocephalusJoon W Shim, Johanna Sandlund, Mustafa Q Hameed, et al.
Experimental Neurology|May 8, 2023
X-linked hydrocephalus genes: Their proximity to telomeres and high A + T content compared to Parkinson's diseaseMadeline Hart, Joshua Conrad, Emma Barrett, et al.
Experimental Neurology|March 23, 2013
VEGF, which is elevated in the CSF of patients with hydrocephalus, causes ventriculomegaly and ependymal changes in ratsJoon W Shim, Johanna Sandlund, Carin H Han, et al.
Frontiers in Genetics|November 21, 2022
TRPV4 mRNA is elevated in the caudate nucleus with NPH but not in Alzheimer's diseaseHunter White, Ryan Webb, Ian McKnight, et al.
Frontiers in Genetics|April 6, 2026
<i>PDK4</i> as a metabolic biomarker of chronic hydrocephalusRobbie Clarke, Payton Villers, Chloe Bills, et al.
JCI Insight|September 17, 2020
TRPV4 antagonists ameliorate ventriculomegaly in a rat model of hydrocephalusAlexandra E Hochstetler, Hillary M Smith, Daniel C Preston, et al.
Frontiers in Aging Neuroscience|June 25, 2024
Reduced GLP-1R availability in the caudate nucleus with Alzheimer's diseaseEmma Barrett, Gabrielle Ivey, Adam Cunningham, et al.
International Journal of Molecular Sciences|June 2, 2021
Factors Associated with Mutations: Their Matching Rates to Cardiovascular and Neurological DiseasesHannah B Lucas, Ian McKnight, Regan Raines, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Biomedicines|March 25, 2022
Drug-Targeted Genomes: Mutability of Ion Channels and GPCRsRegan Raines, Ian McKnight, Hunter White, et al.
Frontiers in Neuroscience|May 21, 2025
NFκB1: a common biomarker linking Alzheimer's and Parkinson's disease pathologyAdam Cunningham, Emma Barrett, Sebastian Risch, et al.
Scientific Reports|June 1, 2016
Excess HB-EGF, which promotes VEGF signaling, leads to hydrocephalusJoon W Shim, Johanna Sandlund, Mustafa Q Hameed, et al.
Experimental Neurology|May 8, 2023
X-linked hydrocephalus genes: Their proximity to telomeres and high A + T content compared to Parkinson's diseaseMadeline Hart, Joshua Conrad, Emma Barrett, et al.
Experimental Neurology|March 23, 2013
VEGF, which is elevated in the CSF of patients with hydrocephalus, causes ventriculomegaly and ependymal changes in ratsJoon W Shim, Johanna Sandlund, Carin H Han, et al.
Frontiers in Genetics|November 21, 2022
TRPV4 mRNA is elevated in the caudate nucleus with NPH but not in Alzheimer's diseaseHunter White, Ryan Webb, Ian McKnight, et al.
Frontiers in Genetics|April 6, 2026
<i>PDK4</i> as a metabolic biomarker of chronic hydrocephalusRobbie Clarke, Payton Villers, Chloe Bills, et al.
JCI Insight|September 17, 2020
TRPV4 antagonists ameliorate ventriculomegaly in a rat model of hydrocephalusAlexandra E Hochstetler, Hillary M Smith, Daniel C Preston, et al.
Frontiers in Aging Neuroscience|June 25, 2024
Reduced GLP-1R availability in the caudate nucleus with Alzheimer's diseaseEmma Barrett, Gabrielle Ivey, Adam Cunningham, et al.
International Journal of Molecular Sciences|June 2, 2021
Factors Associated with Mutations: Their Matching Rates to Cardiovascular and Neurological DiseasesHannah B Lucas, Ian McKnight, Regan Raines, et al.
Pageof 3